Form 4: STAAR Surgical Officer Magda Michna Reports Stock and Options Grants
SEC Form 4 Filing
Magda Michna, Chief Clinical, Regulatory, and Medical Affairs Officer at STAAR Surgical, reports the acquisition of restricted stock units and stock options.
Summary
- Magda Michna, a STAAR Surgical officer, filed a Form 4 on March 13, 2024, reporting transactions on March 12, 2024.
- The transactions involve the grant of 18,533 restricted stock units (RSUs) and 16,599 stock options.
- The RSUs vest in three equal installments on March 12, 2025, 2026, and 2027.
- The stock options vest as to 1/3 on March 12, 2025, with the remaining 2/3 vesting monthly over the following 24 months, concluding on March 12, 2027.
- Michna also has a Limited Power of Attorney designating Nathaniel Sisitsky and Patrick Williams to handle Section 16 reporting obligations.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, incentivizing management. There are no immediate negative implications.
Positives
- The grant of RSUs and stock options could incentivize the officer to perform well, aligning her interests with those of the shareholders.
Industry Context
Stock options and restricted stock units are common forms of executive compensation in the medical device industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Executive compensation packages, including stock options and RSUs, are standard practice among publicly traded medical device companies like Alcon, Johnson & Johnson (specifically their medical device segment), and Medtronic.
- The vesting schedules (1/3 per year for RSUs and a combination of annual and monthly vesting for options) are also typical, designed to incentivize long-term commitment and performance, similar to plans seen at Edwards Lifesciences and Stryker.
Stakeholder Impact
- Shareholders may view the grants as a positive incentive for management.
- Employees may see this as a standard compensation practice.
Key Dates
| Date | Description |
|---|---|
| 03/12/2024 | Date of transaction: Grant of RSUs and stock options. |
| 03/12/2025 | First vesting date for 1/3 of RSUs and stock options. |
| 03/12/2026 | Second vesting date for 1/3 of RSUs. |
| 03/12/2027 | Final vesting date for 1/3 of RSUs and remaining stock options. |
| 03/13/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.